Perisylvian GABA levels in schizophrenia and bipolar disorder
Atagün, M. İ.
Şıkoglu, M. E.
Can, S. S.
Phillips, M. L.
Moore, C. M.
Elsevier Ireland Ltd
70 - 74
Item Usage Stats
MetadataShow full item record
The aim of this study is to measure GABA levels of perisylvian cortices in schizophrenia and bipolar disorder patients, using proton magnetic resonance spectroscopy (1H-MRS). Patients with schizophrenia (n = 25), bipolar I disorder (BD-I; n = 28) and bipolar II disorder (BD-II; n = 20) were compared with healthy controls (n = 30).1H-MRS data was acquired using a Siemens 3 T whole body scanner to quantify right and left perisylvian structures’ (including superior temporal lobes) GABA levels. Right perisylvian GABA values differed significantly between groups [χ2= 9.62, df: 3, p = 0.022]. GABA levels were significantly higher in the schizophrenia group compared with the healthy control group (p = 0.002). Furthermore, Chlorpromazine equivalent doses of antipsychotics correlated with right hemisphere GABA levels (r2= 0.68, p = 0.006, n = 33). GABA levels are elevated in the right hemisphere in patients with schizophrenia in comparison to bipolar disorder and healthy controls. The balance between excitatory and inhibitory controls over the cortical circuits may have direct relationship with GABAergic functions in auditory cortices. In addition, GABA levels may be altered by brain regions of interest, psychotropic medications, and clinical stage in schizophrenia and bipolar disorder. ï¿½ 2016 Elsevier Ireland Ltd
Magnetic resonance spectroscopy
4 aminobutyric acid
atypical antipsychotic agent
4 aminobutyric acid
major clinical study
proton nuclear magnetic resonance
nuclear magnetic resonance spectroscopy
Magnetic Resonance Spectroscopy
Proton Magnetic Resonance Spectroscopy
Published Version (Please cite this version)http://dx.doi.org/10.1016/j.neulet.2016.11.051
Showing items related by title, author, creator and subject.
Investigation of Heschl's gyrus and planum temporale in patients with schizophrenia and bipolar disorder: a proton magnetic resonance spectroscopy study Atagün, M. İ.; Şıkoğlu, E. M.; Can, S. S.; Karakaş-Uğurlu, G.; Ulusoy-Kaymak, S.; Çayköylü, A.; Algın, O.; Phillips, M. L.; Moore, C. M.; Öngür, D. (Elsevier, 2015)Background: Superior temporal cortices include brain regions dedicated to auditory processing and several lines of evidence suggest structural and functional abnormalities in both schizophrenia and bipolar disorder within ...
Neurochemical differences between bipolar disorder type I and II in superior temporal cortices: a proton magnetic resonance spectroscopy study Atagün, M. İ.; Şıkoğlu, E. M.; Can, S. S.; Uğurlu, G. K.; Kaymak, S. U.; Çayköylü, A.; Algın, O.; Phillips, M. L.; Moore, C. M.; Öngür, D. (Elsevier B.V., 2018)Background: Despite the diagnostic challenges in categorizing bipolar disorder subtypes, bipolar I and II disorders (BD-I and BD-II respectively) are valid indices for researchers. Subtle neurobiological differences may ...
Calafato, M. S.; Thygesen, J. H.; Ranlund, S.; Zartaloudi, E.; Cahn, W.; Crespo-Facorro, B.; Díez-Revuelta, A.; Forti, M. D.; Hall, M. -H.; Iyegbe, C.; Jablensky, A.; Kahn, R.; Kalaydjieva, L.; Kravariti, E.; Lin, K.; McDonald, C.; McIntosh, A. M.; McQuillin, A.; Picchioni, M.; Rujescu, D.; Shaikh, M.; Toulopoulou, T.; Os, J. V.; Vassos, E.; Walshe, M.; Powell, J.; Lewis, C. M.; Murray, R. M.; Bramon, E. (2018)Background There is increasing evidence for shared genetic susceptibility between schizophrenia and bipolar disorder. Although genetic variants only convey subtle increases in risk individually, their combination into a ...